Reimbursed Care Access in Gibraltar

Currently classified as a strictly controlled substance under Gibraltar’s controlled‑drugs framework with no authorised medical use or reimbursement outside of approved clinical research. Gibraltar criminal law prohibits possession and supply of controlled drugs except when lawfully possessed by persons acting in the course of their duties (for example medical practitioners under lawful prescription / licensed research) #.

Currently classified as a strictly controlled substance under Gibraltar’s controlled‑drugs framework with no authorised medical use or reimbursement outside of approved clinical research. Possession, supply and production remain offences under Gibraltar law; medical/reimbursement access would be limited to formally licensed clinical trials or exceptional Home Office‑style research licences where applicable. #.

Esketamine (Spravato®) has EU / UK regulatory history (European Commission / MHRA jurisdictions authorised esketamine for treatment‑resistant depression and related indications) but there is no public evidence of an established, Gibraltar‑wide, publicly reimbursed Spravato programme or local formulary listing for routine public health reimbursement. Esketamine’s EU/UK authorisation background (for context) is documented (European Commission / MHRA / EMA product information and UK health‑technology decisions), but Gibraltar does not publish a publicly accessible national medicines reimbursement list showing Spravato as a reimbursed treatment; therefore access in Gibraltar would be expected to occur only via private clinics, importation under clinician prescription, or within formal clinical research and not via a routine, Government‑funded reimbursement programme. For Gibraltar legal framework on controlled drugs and lawful medical possession by clinicians see Gibraltar guidance. # #.

Ketamine is a well established, licit medical anaesthetic and analgesic that may be lawfully possessed and administered by authorised medical practitioners in Gibraltar in the course of their duties; this lawful medical possession is explicitly recognised under Gibraltar guidance for controlled drugs (i.e., medical practitioners may lawfully possess controlled drugs when acting in the course of duty). As an anaesthetic and analgesic it is used in ordinary medical practice and would be available in clinical settings (hospitals, emergency care) when prescribed/administered by authorised clinicians. Off‑label psychiatric uses (e.g., ketamine infusions for depression) are clinical practices in many jurisdictions but carry local regulatory and commissioning implications; there is no publicly published Gibraltar health‑service reimbursement policy specifically endorsing ketamine infusions for treatment‑resistant depression, and any such psychiatric use would likely be arranged through private providers or specialist referral and subject to local clinical governance. #.

Currently classified as a strictly controlled substance under Gibraltar’s controlled‑drugs framework with no authorised medical use or routine reimbursement outside of approved clinical research. Supply, possession and manufacture are criminal offences except for lawful medical/research possession by authorised persons. #.

Currently classified as a strictly controlled substance under Gibraltar’s controlled‑drugs framework with no authorised medical use or routine reimbursement outside of approved clinical research. There is no official medical access pathway or reimbursement programme for 5‑MeO‑DMT in Gibraltar. #.

Currently classified as a strictly controlled substance under Gibraltar’s controlled‑drugs framework with no authorised medical use or routine reimbursement outside of approved clinical research. There is no sanctioned medical/rehabilitative programme reimbursed by public funds in Gibraltar for ibogaine. #.

Because ayahuasca preparations contain internationally controlled tryptamines (e.g., DMT) their possession/supply is treated under Gibraltar’s controlled‑drugs regime; there is no authorised medical/reimbursement pathway for ayahuasca ceremonies or therapeutic use outside of formally approved clinical research. Recreational, ceremonial or unregulated therapeutic use would be unlawful. #.

Mescaline and mescaline extracts are controlled and there is no authorised medical or reimbursed access in Gibraltar outside of approved clinical research. (Note: some jurisdictions distinguish peyote/plant material from extracted mescaline; Gibraltar’s controlled‑drugs framework treats the active psychotropic compounds as controlled where relevant.) #.

Currently classified as a strictly controlled substance (phenethylamine designer/novel psychoactive class) under Gibraltar’s controlled‑drugs laws with no authorised medical use or reimbursement outside of approved clinical research. Supply, possession and manufacture are criminal offences except when lawfully possessed by authorised personnel in the course of duty (e.g., licensed research). #.